Pieter Ruytinx

673 total citations
15 papers, 529 citations indexed

About

Pieter Ruytinx is a scholar working on Immunology, Oncology and Rheumatology. According to data from OpenAlex, Pieter Ruytinx has authored 15 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 6 papers in Oncology and 3 papers in Rheumatology. Recurrent topics in Pieter Ruytinx's work include Chemokine receptors and signaling (6 papers), Immune Response and Inflammation (4 papers) and Immune cells in cancer (3 papers). Pieter Ruytinx is often cited by papers focused on Chemokine receptors and signaling (6 papers), Immune Response and Inflammation (4 papers) and Immune cells in cancer (3 papers). Pieter Ruytinx collaborates with scholars based in Belgium, Brazil and Denmark. Pieter Ruytinx's co-authors include Sofie Struyf, Paul Proost, Jo Van Damme, Mieke Gouwy, Mauro Martins Teixeira, Flávio A. Amaral, Raffaella Bonecchi, Katrien Van Raemdonck, Massimo Locati and Federico Claudi and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Pieter Ruytinx

13 papers receiving 524 citations

Peers

Countries citing papers authored by Pieter Ruytinx

Since Specialization

Citations

This map shows the geographic impact of Pieter Ruytinx's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pieter Ruytinx with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pieter Ruytinx more than expected).

Fields of papers citing papers by Pieter Ruytinx

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pieter Ruytinx. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pieter Ruytinx. The network helps show where Pieter Ruytinx may publish in the future.

Co-authorship network of co-authors of Pieter Ruytinx

This figure shows the co-authorship network connecting the top 25 collaborators of Pieter Ruytinx. A scholar is included among the top collaborators of Pieter Ruytinx based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pieter Ruytinx. Pieter Ruytinx is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	POS0239 INVESTIGATING DUX4 RE-EXPRESSION IN FIBROBLAST-LIKE SYNOVIOCYTES: CELLULAR INSIGHTS FROM TISSUE-DERIVED AND SYNOVIAL FLUID-DERIVED CELLS 2025 ·Annals of the Rheumatic Diseases ·(unknown), Pieter Ruytinx, (unknown), Jan Lenaerts, Kristof Thevissen, (unknown), (unknown), Dominique de Seny, Caroline Ospelt, Veerle Somers	0
2	Fibroblast-like synoviocyte targeting antibodies are associated with failure to reach early and sustained remission or low disease activity after first-line therapy in rheumatoid arthritis 2024 ·RMD Open ·(unknown), Sukayna Fadlallah, Pieter Ruytinx, (unknown), (unknown), Jori Liesenborgs, Johan Joly, Anouk Agten, Frank Vandenabeele, Judith Fraussen, Patrick Verschueren, Veerle Somers	1
3	Antibodies of the immunoglobulin a isotype to novel antigens in early axial spondyloarthritis 2023 ·Frontiers in Medicine ·Pieter Ruytinx, (unknown), (unknown), (unknown), Piet Geusens, J. Vanhoof, Anouk Agten, Frank Vandenabeele, Kurt de Vlam, Veerle Somers	0
4	Comprehensive antibody and cytokine profiling in hospitalized COVID-19 patients in relation to clinical outcomes in a large Belgian cohort 2023 ·Scientific Reports ·Pieter Ruytinx, (unknown), Judith Fraussen, (unknown), (unknown), Niels Hellings, Piet Stinissen, Ina Callebaut, Joris Penders, Karolien Vanhove, Davy Kieffer, Jean‐Luc Rummens, (unknown), Peter Messiaen, Björn Stessel, Dieter Mesotten, Veerle Somers	8
5	The Antimicrobial Activity of Peripheral Blood Neutrophils Is Altered in Patients with Primary Ciliary Dyskinesia 2021 ·International Journal of Molecular Sciences ·(unknown), Marfa Blanter, Mieke Gouwy, Pieter Ruytinx, (unknown), (unknown), Noëmie Pörtner, (unknown), Natalie Lorent, Mieke Boon, Sofie Struyf	6
6	Antibodies Against Three Novel Peptides in Early Axial Spondyloarthritis Patients From Two Independent Cohorts 2020 ·Arthritis & Rheumatology ·(unknown), (unknown), Pieter Ruytinx, Piet Geusens, Kristoff Corten, J. Vanhoof, Jori Liesenborgs, Frank Van Reeth, Anouk Agten, Frank Vandenabeele, Kurt de Vlam, Veerle Somers	9
7	Peroxynitrite Exposure of CXCL12 Impairs Monocyte, Lymphocyte and Endothelial Cell Chemotaxis, Lymphocyte Extravasation in vivo and Anti-HIV-1 Activity 2018 ·Frontiers in Immunology ·Rik Janssens, Daiane Boff, Pieter Ruytinx, Anneleen Mortier, Vincent Vanheule, Olav Larsen, (unknown), Mette M. Rosenkilde, Sam Noppen, Sandra Liekens, Dominique Schols, Ingrid De Meester, Ghislain Opdenakker, Sofie Struyf, Mauro Martins Teixeira, Flávio A. Amaral, Paul Proost	6
8	Chemokine-Induced Macrophage Polarization in Inflammatory Conditions 2018 ·Frontiers in Immunology ·Pieter Ruytinx, Paul Proost, Jo Van Damme, Sofie Struyf	348
9	CXCL4 and CXCL4L1 in cancer 2018 ·Cytokine ·Pieter Ruytinx, Paul Proost, Sofie Struyf	29
10	Intravital Microscopic Evaluation of the Effects of a CXCR2 Antagonist in a Model of Liver Ischemia Reperfusion Injury in Mice 2018 ·Frontiers in Immunology ·(unknown), Pedro Elias Marques, (unknown), Pieter Ruytinx, Flávio A. Amaral, Laura Brandolini, Marcello Allegretti, Paul Proost, Mauro Martins Teixeira	27
11	Anti‐inflammatory effects of the GAG‐binding CXCL9(74‐103) peptide in dinitrofluorobenzene‐induced contact hypersensitivity in mice 2018 ·Clinical & Experimental Allergy ·Vincent Vanheule, (unknown), (unknown), Pieter Ruytinx, Nele Berghmans, Tanja Gerlza, Isabelle Ronsse, Noëmie Pörtner, Patrick Matthys, Andreas J. Kungl, Ghislain Opdenakker, Sofie Struyf, Paul Proost	10
12	Monocytes from patients with Primary Ciliary Dyskinesia show enhanced inflammatory properties and produce higher levels of pro-inflammatory cytokines 2017 ·Scientific Reports ·(unknown), Mieke Gouwy, Pieter Ruytinx, Inge Lodewijckx, (unknown), (unknown), Noëmie Pörtner, Isabelle Ronsse, (unknown), V. Godding, K. De Boeck, Jo Van Damme, Mieke Boon, Sofie Struyf	14
13	Truncation of CXCL12 by CD26 reduces its CXC chemokine receptor 4- and atypical chemokine receptor 3-dependent activity on endothelial cells and lymphocytes 2017 ·Biochemical Pharmacology ·Rik Janssens, Anneleen Mortier, Daiane Boff, Pieter Ruytinx, Mieke Gouwy, (unknown), Olav Larsen, (unknown), Mette M. Rosenkilde, Marc Parmentier, Sam Noppen, Sandra Liekens, Jo Van Damme, Sofie Struyf, Mauro Martins Teixeira, Flávio A. Amaral, Paul Proost	39
14	Relative distribution and biological characterization of CXCL4L1 isoforms in platelets from healthy donors 2017 ·Biochemical Pharmacology ·Pieter Ruytinx, Rik Janssens, Nele Berghmans, Mieke Gouwy, Isabelle Ronsse, Sandra Liekens, Paul Proost, Jo Van Damme, Sofie Struyf	4
15	CXCL4 and CXCL4L1 Differentially Affect Monocyte Survival and Dendritic Cell Differentiation and Phagocytosis 2016 ·PLoS ONE ·Mieke Gouwy, Pieter Ruytinx, (unknown), Federico Claudi, Katrien Van Raemdonck, Raffaella Bonecchi, Massimo Locati, Sofie Struyf	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact